BRD4 (Bromodomain-containing protein 4) variants and mutations
BRD4 (also known as Bromodomain-containing protein 4) is a human protein-coding gene encoding a bromodomain-containing protein 4 protein. It remains associated with acetylated chromatin and recruits transcriptional elongation machinery to sustain expression of growth and identity genes. Cancer cells can become highly dependent on BRD4-driven transcription, making it a major target of BET inhibitors and protein degraders. This analysis covers 2,719 BRD4 variants and mutations. Of these, 86% have computational variant effect predictions. Disease context includes Cornelia de Lange syndrome 6, Cornelia de Lange syndrome, and neoplasm. Example BRD4 variants include S2C, S2F, and A3V.
Variant analysis overview
- Gene: BRD4
- Protein: Bromodomain-containing protein 4
- UniProt accession: O60885
- Organism: Homo sapiens
- Variants analyzed: 2719
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 2,434 unspecified-consequence records; 118 synonymous variants; 124 missense variants; 2 splice-region variants; 14 stop-gained variants; 15 in-frame deletions; 3 frameshift variants; 8 in-frame insertions; 1 substitution
- Prediction scores: 2,336 variants have prediction scores (86% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Cornelia de Lange syndrome 6, Cornelia de Lange syndrome, neoplasm, syndromic intellectual disability, 3q26 microduplication syndrome, hereditary disease, esophageal squamous cell carcinoma, nut midline carcinoma, colon adenocarcinoma, cutaneous melanoma, skin squamous cell carcinoma, squamous cell lung carcinoma.
Protein structure and variant hotspots
- Protein features: 3 domains; 14 post-translational modification sites.
- Structural context: 382 variants have structural context.
- PTM context: 29 variants overlap post-translational modification sites.
- Experimental data: 67 protein positions have experimental scores. Source: BRD4 NET domain domainome 1.0.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable BRD4 variants
Examples include S2C, S2F, A3V, E4*, S5N, G6A, G6S, P7H. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2C (p.Ser2Cys), Ensembl rs2047607632
- S2F (p.Ser2Phe), Ensembl rs2047607632, MetaLR 0.09, MetaSVM -1.01
- A3V (p.Ala3Val), TOPMed rs1324868843, gnomAD rs1324868843, MetaLR 0.03, MetaSVM -1.00, Uncertain significance, not provided
- E4* (p.Glu4Ter), gnomAD rs2047607504, CADD 36.00
- S5N (p.Ser5Asn), ExAC rs750300459, TOPMed rs750300459, gnomAD rs750300459, MetaLR 0.07, MetaSVM -0.99, Uncertain significance, not provided
- G6A (p.Gly6Ala), rs199609038, ClinGen CA9265729, ClinVar RCV003552408, ClinVar RCV006332282, MetaLR 0.06, MetaSVM -1.12, Uncertain significance, Inborn genetic diseases; not provided
- G6S (p.Gly6Ser), TOPMed rs200468125, gnomAD rs200468125, MetaLR 0.07, MetaSVM -1.09
- P7H (p.Pro7His), NCI-TCGA TCGA novel, MetaLR 0.21, MetaSVM -0.74, Variant assessed as somatic; moderate impact.
- P7R (p.Pro7Arg), rs1415180178, ClinGen CA404490392, ClinVar RCV003083090, TOPMed rs1415180178, MetaLR 0.19, MetaSVM -0.81, Uncertain significance, not provided
- G8V (p.Gly8Val), Ensembl rs2145625592, MetaLR 0.19, MetaSVM -0.76
- T9K (p.Thr9Lys), rs921948175, ClinGen CA305783300, ClinVar RCV003725521, ClinVar RCV006332328, MetaLR 0.07, MetaSVM -1.11, Uncertain significance, Inborn genetic diseases; not provided
- T9M (p.Thr9Met), NCI-TCGA Cosmic COSV5459, cosmic curated COSV54590, TOPMed rs921948175, gnomAD rs921948175, MetaLR 0.15, MetaSVM -0.93, Uncertain significance
- T9R (p.Thr9Arg), TOPMed rs921948175, gnomAD rs921948175, MetaLR 0.14, MetaSVM -1.03, Uncertain significance
- R10G (p.Arg10Gly), rs2512606655, ClinGen CA404490361, ClinVar RCV003944290, Uncertain significance, BRD4-related disorder
- R10I (p.Arg10Ile), NCI-TCGA TCGA novel, MetaLR 0.24, MetaSVM -0.64, Variant assessed as somatic; moderate impact.
- L11F (p.Leu11Phe), NCI-TCGA Cosmic COSV5458, cosmic curated COSV54585, Variant assessed as somatic; moderate impact.
- R12T (p.Arg12Thr), Ensembl rs2145625541, MetaLR 0.11, MetaSVM -0.90
- N13H (p.Asn13His), gnomAD rs1190159775, MetaLR 0.05, MetaSVM -1.04
- N13K (p.Asn13Lys), Ensembl rs2145625515, MetaLR 0.05, MetaSVM -1.04
- N13S (p.Asn13Ser), gnomAD rs1465170573, MetaLR 0.05, MetaSVM -1.04
- L14V (p.Leu14Val), Ensembl rs2145625511, MetaLR 0.04, MetaSVM -1.07
- P15L (p.Pro15Leu), rs369254108, cosmic curated COSV54586, ESP rs369254108, TOPMed rs369254108, MetaLR 0.11, MetaSVM -1.01, Variant assessed as somatic; moderate impact.
- P15R (p.Pro15Arg), ESP rs369254108, TOPMed rs369254108, gnomAD rs369254108, MetaLR 0.11, MetaSVM -1.00
- P15S (p.Pro15Ser), gnomAD rs2047606919, MetaLR 0.02, MetaSVM -0.98
- V16E (p.Val16Glu), Ensembl rs2145625467
- M17I (p.Met17Ile), cosmic curated COSV10584, NCI-TCGA TCGA novel, ExAC rs763841109, TOPMed rs763841109, MetaLR 0.09, MetaSVM -1.04, Variant assessed as somatic; moderate impact.
- M17K (p.Met17Lys), Ensembl rs2145625448, MetaLR 0.08, MetaSVM -1.05
- D19G (p.Asp19Gly), NCI-TCGA Cosmic COSV9965, cosmic curated COSV99650, Ensembl rs2145625424, MetaLR 0.17, MetaSVM -0.83, Variant assessed as somatic; moderate impact.
- G20* (p.Gly20Ter), Ensembl rs527856622
- G20E (p.Gly20Glu), gnomAD rs1290547844, MetaLR 0.21, MetaSVM -0.74
- G20R (p.Gly20Arg), Ensembl rs527856622, MetaLR 0.17, MetaSVM -0.80
- G20V (p.Gly20Val), gnomAD rs1290547844, MetaLR 0.24, MetaSVM -0.64
- L21P (p.Leu21Pro), ExAC rs762451591, TOPMed rs762451591, gnomAD rs762451591, MetaLR 0.14, MetaSVM -0.91
- L21Q (p.Leu21Gln), ExAC rs762451591, TOPMed rs762451591, gnomAD rs762451591, MetaLR 0.14, MetaSVM -0.91
- E22K (p.Glu22Lys), Ensembl rs2047606670, MetaLR 0.16, MetaSVM -0.87
- T23A (p.Thr23Ala), NCI-TCGA TCGA novel, Ensembl rs2145625363, MetaLR 0.04, MetaSVM -1.04, Variant assessed as somatic; moderate impact.
- T23I (p.Thr23Ile), cosmic curated COSV54581, ExAC rs777108318, gnomAD rs777108318, MetaLR 0.06, MetaSVM -1.01
- T23N (p.Thr23Asn), ExAC rs777108318, gnomAD rs777108318, MetaLR 0.06, MetaSVM -1.01
- S24C (p.Ser24Cys), TOPMed rs1229502583, gnomAD rs1229502583, MetaLR 0.05, MetaSVM -1.05
- S24F (p.Ser24Phe), TOPMed rs1229502583, gnomAD rs1229502583, MetaLR 0.04, MetaSVM -1.06
- S24P (p.Ser24Pro), gnomAD rs1300082154, MetaLR 0.02, MetaSVM -1.06
- Q25R (p.Gln25Arg), gnomAD rs2047606477, MetaLR 0.15, MetaSVM -0.97
- M26I (p.Met26Ile), Ensembl rs2145625269, MetaLR 0.13, MetaSVM -1.01
- S27A (p.Ser27Ala), gnomAD rs2047606407, MetaLR 0.09, MetaSVM -1.04
- S27C (p.Ser27Cys), Ensembl rs2145625250
- T28A (p.Thr28Ala), ExAC rs773685828, TOPMed rs773685828, gnomAD rs773685828, MetaLR 0.04, MetaSVM -1.02
- T28I (p.Thr28Ile), TOPMed rs1944776133, MetaLR 0.05, MetaSVM -1.06
- T29S (p.Thr29Ser), Ensembl rs2145625215, MetaLR 0.05, MetaSVM -1.11
- Q30P (p.Gln30Pro), Ensembl rs978810316
- A31S (p.Ala31Ser), TOPMed rs1408837255, gnomAD rs1408837255, MetaLR 0.12, MetaSVM -0.97
- Q32E (p.Gln32Glu), rs2512606209, ClinGen CA404489921, ClinVar RCV004434308, Uncertain significance, Inborn genetic diseases
- Q32R (p.Gln32Arg), rs772517257, ClinGen CA9265720, ClinVar RCV002611662, ClinVar RCV004603302, MetaLR 0.05, MetaSVM -1.07, Uncertain significance, Inborn genetic diseases; not provided
- A33S (p.Ala33Ser), ExAC rs748256356, gnomAD rs748256356, MetaLR 0.05, MetaSVM -1.07
- A33T (p.Ala33Thr), ExAC rs748256356, gnomAD rs748256356
- A33V (p.Ala33Val), rs201539391, ClinGen CA305783232, NCI-TCGA Cosmic COSV9965, cosmic curated COSV99651, MetaLR 0.07, MetaSVM -0.99, Uncertain significance, not provided
- Q34H (p.Gln34His), Ensembl rs1599474204, MetaLR 0.10, MetaSVM -1.08
- Q34P (p.Gln34Pro), Ensembl rs2145625151
- P35A (p.Pro35Ala), gnomAD rs2047605830, MetaLR 0.08, MetaSVM -1.09
- P35S (p.Pro35Ser), gnomAD rs2047605830, MetaLR 0.14, MetaSVM -0.99
- Q36H (p.Gln36His), Ensembl rs2145625128
- P37S (p.Pro37Ser), rs35177876, ClinGen CA305783225, ClinVar RCV003383989, UniProt VAR 041919, AlphaMissense 0.07, MetaLR 0.05, Uncertain significance, Inborn genetic diseases
- A38D (p.Ala38Asp), Ensembl rs2047605745, MetaLR 0.03, MetaSVM -1.08
- A38P (p.Ala38Pro), Ensembl rs2145625108
- A38T (p.Ala38Thr), Ensembl rs2145625108
- A38V (p.Ala38Val), Ensembl rs2047605745, MetaLR 0.04, MetaSVM -1.07
- N39S (p.Asn39Ser), TOPMed rs2047605708, MetaLR 0.03, MetaSVM -0.99
- A40P (p.Ala40Pro), ExAC rs768982122, TOPMed rs768982122, gnomAD rs768982122, Uncertain significance
- A40S (p.Ala40Ser), rs768982122, ClinGen CA404489769, ClinVar RCV003579403, ExAC rs768982122, AlphaMissense 0.08, MetaLR 0.02, Uncertain significance, not provided
- A40T (p.Ala40Thr), rs768982122, ClinGen CA9265717, NCI-TCGA Cosmic COSV5458, cosmic curated COSV54583, AlphaMissense 0.08, MetaLR 0.02, Uncertain significance, not provided
- A40V (p.Ala40Val), rs866414198, ClinGen CA305783205, ClinVar RCV003703433, TOPMed rs866414198, MetaLR 0.05, MetaSVM -1.03, Uncertain significance, not provided
- A41G (p.Ala41Gly), TOPMed rs1042996398, gnomAD rs1042996398, MetaLR 0.05, MetaSVM -1.03
- A41T (p.Ala41Thr), Ensembl rs2145625050, MetaLR 0.05, MetaSVM -1.06
- A41V (p.Ala41Val), TOPMed rs1042996398, gnomAD rs1042996398, MetaLR 0.04, MetaSVM -1.04, Uncertain significance, not provided
- S42N (p.Ser42Asn), Ensembl rs2145625014, MetaLR 0.03, MetaSVM -1.04
- T43A (p.Thr43Ala), rs201234217, ClinGen CA9265716, ClinVar RCV003706849, ExAC rs201234217, MetaLR 0.01, MetaSVM -0.95, Uncertain significance, not provided
- T43I (p.Thr43Ile), ExAC rs779939979, TOPMed rs779939979, gnomAD rs779939979, MetaLR 0.03, MetaSVM -1.04
- T43S (p.Thr43Ser), ExAC rs201234217, TOPMed rs201234217, gnomAD rs201234217, MetaLR 0.01, MetaSVM -0.98, Uncertain significance
- P45H (p.Pro45His), Ensembl rs2145624975, MetaLR 0.14, MetaSVM -1.01
- P45S (p.Pro45Ser), Ensembl rs2145624979, MetaLR 0.12, MetaSVM -1.07
- P46L (p.Pro46Leu), cosmic curated COSV10961, TOPMed rs1229253526, gnomAD rs1229253526, MetaLR 0.07, MetaSVM -1.11
- P46Q (p.Pro46Gln), TOPMed rs1229253526, gnomAD rs1229253526, MetaLR 0.09, MetaSVM -1.11
- P46S (p.Pro46Ser), rs1331613863, NCI-TCGA Cosmic COSV5458, cosmic curated COSV54587, TOPMed rs1331613863, MetaLR 0.04, MetaSVM -1.13, Uncertain significance, not provided
- P46T (p.Pro46Thr), TOPMed rs1331613863, gnomAD rs1331613863
- P47A (p.Pro47Ala), gnomAD rs1301560534, MetaLR 0.10, MetaSVM -1.10
- P47S (p.Pro47Ser), gnomAD rs1301560534, MetaLR 0.12, MetaSVM -1.06
- P47T (p.Pro47Thr), gnomAD rs1301560534, MetaLR 0.14, MetaSVM -0.97
- P48A (p.Pro48Ala), NCI-TCGA Cosmic COSV9965, cosmic curated COSV99650, Variant assessed as somatic; moderate impact.
- E49G (p.Glu49Gly), cosmic curated COSV54587, Ensembl rs2145624885
- E49Q (p.Glu49Gln), Ensembl rs2145624891, MetaLR 0.04, MetaSVM -1.09
- T50I (p.Thr50Ile), Ensembl rs960200984
- T50P (p.Thr50Pro), Ensembl rs1599474065
- T50S (p.Thr50Ser), Ensembl rs1599474065, MetaLR 0.03, MetaSVM -1.05
- S51C (p.Ser51Cys), cosmic curated COSV54587, ExAC rs750187537, TOPMed rs750187537, gnomAD rs750187537, MetaLR 0.06, MetaSVM -1.12
- S51F (p.Ser51Phe), ExAC rs750187537, TOPMed rs750187537, gnomAD rs750187537, MetaLR 0.06, MetaSVM -1.08
- S51Y (p.Ser51Tyr), ExAC rs750187537, TOPMed rs750187537, gnomAD rs750187537, MetaLR 0.06, MetaSVM -1.09
- N52H (p.Asn52His), Ensembl rs2145624832
- N52K (p.Asn52Lys), TOPMed rs2047604857, MetaLR 0.05, MetaSVM -1.14
- N52S (p.Asn52Ser), Ensembl rs202100137, MetaLR 0.04, MetaSVM -1.09
- P53H (p.Pro53His), Ensembl rs2145624813, MetaLR 0.16, MetaSVM -0.80
- N54I (p.Asn54Ile), cosmic curated COSV10809, TOPMed rs2047604768, MetaLR 0.05, MetaSVM -0.98
- N54S (p.Asn54Ser), NCI-TCGA Cosmic COSV9965, cosmic curated COSV99651, TOPMed rs2047604768, MetaLR 0.02, MetaSVM -1.02, Variant assessed as somatic; moderate impact.
- K55N (p.Lys55Asn), Ensembl rs2145624775
- K55R (p.Lys55Arg), ESP rs368453549, TOPMed rs368453549, gnomAD rs368453549, MetaLR 0.03, MetaSVM -1.08
- K55T (p.Lys55Thr), NCI-TCGA Cosmic COSV9965, cosmic curated COSV99650, MetaLR 0.04, MetaSVM -1.06, Variant assessed as somatic; moderate impact.
- P56H (p.Pro56His), cosmic curated COSV54586, Ensembl rs2145624767, MetaLR 0.15, MetaSVM -0.88
- K57N (p.Lys57Asn), Ensembl rs2145624745, MetaLR 0.07, MetaSVM -1.11
- R58K (p.Arg58Lys), Ensembl rs2145624736
- R58S (p.Arg58Ser), Ensembl rs2145624728
- Q59* (p.Gln59Ter), Ensembl rs2145624720
- Q59H (p.Gln59His), gnomAD rs1372950328
- N61I (p.Asn61Ile), Ensembl rs2145624698
- N61K (p.Asn61Lys), TOPMed rs2047604570, MetaLR 0.13, MetaSVM -0.93
- Q64* (p.Gln64Ter), NCI-TCGA Cosmic COSV5459, cosmic curated COSV54592, Variant assessed as somatic; high impact.
- Q64R (p.Gln64Arg), Ensembl rs2047604486, MetaLR 0.13, MetaSVM -0.95
- Y65N (p.Tyr65Asn), Ensembl rs2145624650
- L66M (p.Leu66Met), Ensembl rs2145624645
- L67H (p.Leu67His), ExAC rs762728554, gnomAD rs762728554
- L67R (p.Leu67Arg), ExAC rs762728554, gnomAD rs762728554
- L67V (p.Leu67Val), Ensembl rs2145624629
- R68K (p.Arg68Lys), gnomAD rs1002212228, MetaLR 0.05, MetaSVM -1.05, Uncertain significance
- R68T (p.Arg68Thr), rs1002212228, ClinGen CA305783078, ClinVar RCV003665285, gnomAD rs1002212228, MetaLR 0.04, MetaSVM -1.05, Uncertain significance, not provided
- L71H (p.Leu71His), Ensembl rs2145624575
- L71P (p.Leu71Pro), cosmic curated COSV54583, Ensembl rs2145624575
- K72Q (p.Lys72Gln), TOPMed rs1362402277, MetaLR 0.14, MetaSVM -0.92
- K72R (p.Lys72Arg), cosmic curated COSV54585, TOPMed rs1173805182, gnomAD rs1173805182, MetaLR 0.11, MetaSVM -0.98
- L74Q (p.Leu74Gln), Ensembl rs2145624538, MetaLR 0.42, MetaSVM 0.16
- Q78H (p.Gln78His), ExAC rs772582586, gnomAD rs772582586, MetaLR 0.03, MetaSVM -1.06
- A80V (p.Ala80Val), Ensembl rs2145624480, MetaLR 0.19, MetaSVM -0.80
- W81C (p.Trp81Cys), Ensembl rs2145624465, MetaLR 0.23, MetaSVM -0.57
- P82A (p.Pro82Ala), Ensembl rs2145624455
- P82L (p.Pro82Leu), Ensembl rs2145624445, MetaLR 0.18, MetaSVM -0.76
- F83L (p.Phe83Leu), Ensembl rs2145624436, MetaLR 0.61, MetaSVM 0.47
- Q84* (p.Gln84Ter), Ensembl rs2145624429
- Q84H (p.Gln84His), Ensembl rs1599473923
- Q85* (p.Gln85Ter), Ensembl rs2145624409
- Q85E (p.Gln85Glu), Ensembl rs2145624409, MetaLR 0.04, MetaSVM -1.07
- P86A (p.Pro86Ala), TOPMed rs2047603834
- P86S (p.Pro86Ser), TOPMed rs2047603834, MetaLR 0.28, MetaSVM -0.25
- V87E (p.Val87Glu), Ensembl rs2145624367
- D88H (p.Asp88His), Ensembl rs2145624337
- D88V (p.Asp88Val), rs2145624320, ClinGen CA404488689, ClinVar RCV001755169, Ensembl rs2145624320, AlphaMissense 0.99, MetaLR 0.27, Uncertain significance, not provided
- A89T (p.Ala89Thr), Ensembl rs2145624299
- A89V (p.Ala89Val), NCI-TCGA Cosmic COSV5458, cosmic curated COSV54589, Ensembl rs2145624285, MetaLR 0.05, MetaSVM -1.15, Variant assessed as somatic; moderate impact.
- V90D (p.Val90Asp), Ensembl rs2145624269, MetaLR 0.14, MetaSVM -0.94
- V90I (p.Val90Ile), rs201971332, ExAC rs201971332, TOPMed rs201971332, gnomAD rs201971332, MetaLR 0.07, MetaSVM -1.10, Variant assessed as somatic; moderate impact.
- K91R (p.Lys91Arg), 1000Genomes rs559089423, ExAC rs559089423, gnomAD rs559089423, MetaLR 0.12, MetaSVM -1.02
- N93K (p.Asn93Lys), Ensembl rs1568392191, MetaLR 0.08, MetaSVM -1.09
- L94P (p.Leu94Pro), Ensembl rs2145624205
- P95L (p.Pro95Leu), ExAC rs757320209, gnomAD rs757320209, MetaLR 0.24, MetaSVM -0.57
- P95S (p.Pro95Ser), rs1409879003, NCI-TCGA Cosmic COSV5458, cosmic curated COSV54586, gnomAD rs1409879003, MetaLR 0.27, MetaSVM -0.46, Variant assessed as somatic; moderate impact.
- D96H (p.Asp96His), Ensembl rs2145613729
- D96N (p.Asp96Asn), NCI-TCGA Cosmic COSV5458, cosmic curated COSV54582, MetaLR 0.19, MetaSVM -0.65, Variant assessed as somatic; moderate impact.
- Y97* (p.Tyr97Ter), Ensembl rs2145613707
- K99N (p.Lys99Asn), ExAC rs763461840, TOPMed rs763461840, gnomAD rs763461840, MetaLR 0.08, MetaSVM -1.08
- K102N (p.Lys102Asn), TOPMed rs2047560654, MetaLR 0.16, MetaSVM -0.68
- K102R (p.Lys102Arg), Ensembl rs1382125723, MetaLR 0.14, MetaSVM -0.83
- T103K (p.Thr103Lys), ESP rs200203571, ExAC rs200203571, TOPMed rs200203571, gnomAD rs200203571, MetaLR 0.02, MetaSVM -1.03, Uncertain significance
- T103M (p.Thr103Met), rs200203571, ClinGen CA9265661, ClinVar RCV003082996, ESP rs200203571, MetaLR 0.17, MetaSVM -0.57, Uncertain significance, not provided
- T103S (p.Thr103Ser), gnomAD rs1246321668, MetaLR 0.05, MetaSVM -1.06
- T109R (p.Thr109Arg), Ensembl rs2145613612, MetaLR 0.37, MetaSVM -0.07
- K112M (p.Lys112Met), TOPMed rs199654568, gnomAD rs199654568, MetaLR 0.27, MetaSVM -0.40
- K112R (p.Lys112Arg), TOPMed rs199654568, gnomAD rs199654568, MetaLR 0.16, MetaSVM -0.91
- K112T (p.Lys112Thr), TOPMed rs199654568, gnomAD rs199654568, MetaLR 0.21, MetaSVM -0.68
- R113C (p.Arg113Cys), NCI-TCGA Cosmic COSV5458, NCI-TCGA Cosmic COSV5459, cosmic curated COSV54590, Ensembl rs2145613568, Variant assessed as somatic; moderate impact.
- R113H (p.Arg113His), cosmic curated COSV99651, Ensembl rs2145613555, Uncertain significance, not provided
- R113L (p.Arg113Leu), rs2145613555, ClinGen CA404486643, ClinVar RCV003697527, AlphaMissense 0.99, MetaLR 0.19, Likely pathogenic, not provided
- L114M (p.Leu114Met), Ensembl rs2145613545
- E115Q (p.Glu115Gln), Ensembl rs2145613533, MetaLR 0.10, MetaSVM -1.02
- N117S (p.Asn117Ser), rs772991598, ClinGen CA9265657, cosmic curated COSV54588, ClinVar RCV002684272, MetaLR 0.07, MetaSVM -1.00, Uncertain significance, Inborn genetic diseases
- W120* (p.Trp120Ter), ExAC rs748114590
- W120C (p.Trp120Cys), cosmic curated COSV54585, ExAC rs748114590, MetaLR 0.15, MetaSVM -0.94
- Q123E (p.Gln123Glu), NCI-TCGA Cosmic COSV5458, cosmic curated COSV54585, Variant assessed as somatic; moderate impact.
- E124D (p.Glu124Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E124Q (p.Glu124Gln), Ensembl rs2145613498, MetaLR 0.13, MetaSVM -0.98
- C125Y (p.Cys125Tyr), NCI-TCGA Cosmic COSV5459, cosmic curated COSV54590, MetaLR 0.17, MetaSVM -0.85, Variant assessed as somatic; moderate impact.
- Q127P (p.Gln127Pro), rs2512595833, ClinGen CA404486387, ClinVar RCV003350227, Uncertain significance, Inborn genetic diseases
- F129L (p.Phe129Leu), NCI-TCGA Cosmic COSV5458, cosmic curated COSV54582, MetaLR 0.07, MetaSVM -1.11, Variant assessed as somatic; moderate impact.
- T131I (p.Thr131Ile), Ensembl rs2145613466, MetaLR 0.09, MetaSVM -1.10
- F133L (p.Phe133Leu), Ensembl rs2145613458, MetaLR 0.24, MetaSVM -0.55
- C136* (p.Cys136Ter), TOPMed rs2047559994
Public BRD4 analysis runs
- BRD4 analysis run — BRD4 (2,719 variants) — completed 2026-08-19